drugset / Trial / NCT02596997

Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease

NCT02596997 ↗

Expanded access No longer available Jazz Pharmaceuticals

Summary

Provide patients with serious AdV infection or disease access to treatment with BCV.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Brincidofovir Other / unclassified 100 mg —